You just read:

Research and Markets - Combination Antibody Therapy for Cancer Treatment Overview 2016 Featuring BioPlan Associates, Eureka Therapeutics, Lonza Group, Peregrine Pharmaceuticals & Symphogen

News provided by

Research and Markets

13 Jun, 2016, 21:10 BST